SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-12-003459
Filing Date
2012-09-26
Accepted
2012-09-26 17:12:22
Documents
3
Period of Report
2012-09-24
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K peregrine_8k.htm 8-K 21267
2 PRESS RELEASE peregrine_ex9901.htm EX-99.1 8134
3 GRAPHIC image_002.jpg GRAPHIC 3079
  Complete submission text file 0001019687-12-003459.txt   35195
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 121111530
SIC: 2834 Pharmaceutical Preparations